ICI in UC: Argentina
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina

Released: February 22, 2021

Expiration: February 21, 2022

Alejandro Nolazco
Alejandro Nolazco, MD

Activity

Progress
1
Course Completed

In this episode, José Ignacio Nolazco, MD, and Alejandro Nolazco, MD, discuss in Spanish the latest immuno-oncology developments in the treatment of urothelial cancer from an Argentinian perspective.  

Presenters:

José Ignacio Nolazco, MD  
Urology Fellow
Hospital Universitario Austral
Buenos Aires, Argentina

Alejandro Nolazco, MD
Associate Professor
Department of Urology
Universidad Austral and Universidad Católica Argentina
Buenos Aires, Argentina